Browsing: pfizer
When Pfizer CEO Albert Bourla asked his employees to compress years of vaccine development and manufacturing into months, he knew…
After leading Pfizer through the frantic race to develop the first FDA-approved COVID-19 vaccine, CEO Albert Bourla has set his…
Pfizer CEO Albert Bourla says he used extreme team-motivating tactics to meet seemingly impossible deadlines during the COVID-19 pandemic. In…
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
President Trump’s recent agreements with Pfizer and AstraZeneca have drawn attention for lowering drug costs and incentivizing domestic manufacturing. Equally…
Pfizer and AstraZeneca’s recent drug-pricing deals with the Trump Administration mark a sharp shift in how Washington is approaching the…
At a news conference this week, President Trump touted a deal with Pfizer in which the drug company will sell…
Pfizer $4.9 billion cash acquisition of Metsera, a clinical-stage biotech focused on next-generation obesity drugs, is more than another high-profile…
President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks like the pharmaceutical giant got…
The CDC’s immunization advisory committee—whose membership Health and Human Services Secretary Robert F. Kennedy Jr. purged in June and replaced…